Geltor In The News.

December 19, 2017

Geltor is the subject of a Fortune article! “In 2015 Nick Ouzounov and Alexander Lorestani applied to the San Francisco–based biotech accelerator IndieBio. The two Princeton Ph.D.s had an idea for a way to engineer a microbe that could build vast amounts of protein designed for specific functions. They envisioned that it could have biopharma […]

Read More